37 studies found for:    "Thyroid cancer anaplastic"
Show Display Options
Rank Status Study
21 Completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
Conditions: Metastatic Differentiated Thyroid Cancer;   Metastatic Poorly Differentiated Thyroid Cancer;   Metastatic Anaplastic Thyroid Cancer;   Metastatic Medullary Thyroid Cancer
Intervention: Drug: sorafenib
22 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Biological: filgrastim;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
23 Unknown  Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: pemetrexed + paclitaxel
24 Recruiting Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
Condition: Thyroid Carcinoma
Intervention: Drug: Sorafenib (Nexavar,BAY43-9006)
25 Completed Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Conditions: Colorectal Cancer;   Head and Neck Cancer;   Metastatic Cancer
Interventions: Drug: boronophenylalanine-fructose complex;   Drug: sodium borocaptate;   Procedure: conventional surgery
26 Unknown  Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
Condition: Head and Neck Cancer
Intervention: Drug: everolimus
27 Completed NGR-TNF in Treating Patients With Advanced Solid Tumors
Conditions: Colorectal Cancer;   Head and Neck Cancer;   Kidney Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: CNGRC peptide-TNF alpha conjugate
28 Completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Conditions: Adrenocortical Carcinoma;   Brain and Central Nervous System Tumors;   Head and Neck Cancer;   Liver Cancer;   Malignant Mesothelioma;   Pheochromocytoma;   Sarcoma
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: conventional surgery;   Radiation: radiation therapy
29 Terminated Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
Conditions: Melanoma;   Thyroid Cancer;   Colorectal Cancer;   Non-small Cell Lung Cancer;   Cholangiocarcinoma;   Histiocytosis;   Hairy Cell Leukemia
Intervention: Drug: PLX8394
30 Completed Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Conditions: Colorectal Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Liver Cancer;   Lung Cancer;   Melanoma (Skin);   Pancreatic Cancer;   Testicular Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: aldesleukin;   Biological: ras peptide cancer vaccine;   Biological: sargramostim;   Drug: DetoxPC
31 Completed Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Condition: Cancer
Interventions: Biological: trastuzumab;   Drug: tipifarnib
32 Unknown  Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
Condition: Head and Neck Cancer
Intervention: Drug: gefitinib
33 Completed Iodine I 131 in Treating Patients With Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Procedure: computed tomography;   Procedure: radionuclide imaging;   Procedure: single photon emission computed tomography;   Radiation: iodine I 131
34 Withdrawn S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer;   Head and Neck Cancer;   Lung Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: docetaxel;   Drug: vandetanib;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis;   Other: pharmacological study
35 Completed SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck
Condition: Head and Neck Cancer
Interventions: Drug: paclitaxel;   Drug: semaxanib
36 Recruiting Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Drug: everolimus;   Other: laboratory biomarker analysis
37 Recruiting A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Conditions: Differentiated Thyroid Cancer (DTC);   Poorly Differentiated Thyroid Cancer
Intervention: Drug: Cabozantinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years